New tests launched in September

New Tests

In September 2022, Mayo Clinic Laboratories announced ten new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

The new tests that launched in September 2022 by Mayo Clinic Laboratories:

BRBPS | Broad Range Bacterial PCR and Sequencing, Varies

This test is intended for detecting and identifying bacteria (including mycobacteria) from normally sterile sources, including synovial fluid; body fluids such as pleural, peritoneal, and pericardial fluids, cerebrospinal fluid; and both fresh and formalin-fixed paraffin-embedded tissues.

C1INF | C1 Esterase Inhibitor, Functional, Serum

This test is intended for diagnosing hereditary angioedema, and monitoring response to C1 esterase inhibitor replacement therapy.

HEVQU | Hepatitis E Virus RNA Detection and Quantification, Real-Time RT-PCR, Serum

This test is intended for Virologic detection and confirmation of hepatitis E virus (HEV) infection in individuals who are immunocompromised and are at risk for or suspected to have acute or chronic hepatitis E.

KLF1 | KLF1 Full Gene Sequencing, Varies

This test is intended for aiding in the diagnosis and carrier detection of KLF1 sequence alterations that are reported to be responsible for neonatal anemia or jaundice, hydrops fetalis, increased fetal hemoglobin and hemoglobin A2.

This test is intended for the detection of non-variola Orthopoxvirus in individuals presenting with signs and symptoms suggestive of monkeypox.

MSUSC | Branched-Chain Amino Acids, Self-Collect, Blood Spot

This test is intended for monitoring patients with maple-syrup urine disease using specimens collected at home.

PETH | Phosphatidylethanol Confirmation, Blood

This test is intended for verifying abstinence or use of ethanol especially in liver transplant candidates/patients

In addition to these tests, the department also announced several test changes. Click the links below to view test changes announced by Mayo Clinic Laboratories:

Samantha Rossi

Samantha Rossi is a Digital Marketing Manager at Mayo Clinic Laboratories. She supports marketing strategies for product management and specialty testing. Samantha has worked at Mayo Clinic since 2019.